Back to Poisoning Toxicology Environmental Health
Biodefense and Bioterrorism
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Poisoning Toxicology Environmental Health

Biodefense and Bioterrorism

A bioterrorism attack involves the deliberate release of germs to cause illness, while biodefense measures work to protect the public through medical research and preparation.

Understanding Bioterrorism

A bioterrorism attack is the deliberate release of viruses, bacteria, or other germs to cause illness or death. While these germs are often found in nature, they can sometimes be modified to be more harmful by increasing their ability to cause disease, spread, or resist medical treatment.

Transmission and Detection

Biological agents can spread through the air, water, or food, and some may spread from person to person. These agents are often difficult to detect because they do not cause illness for several hours or days. Potential biological agents of concern include:

  • Anthrax
  • Botulism
  • Ebola and other hemorrhagic fever viruses
  • Plague
  • Smallpox

Biodefense

Biodefense utilizes medical measures to protect people against bioterrorism. This includes the use of medicines and vaccinations, as well as ongoing medical research and preparations to defend against potential attacks.

Source: Centers for Disease Control and Prevention

Frequently Asked Questions

Yes, post-exposure vaccination is effective against specific agents when given within a precise therapeutic window. For example, administering the smallpox vaccine within three to four days of initial viral exposure can prevent clinical smallpox or substantially lessen the severity of the illness. Similarly, the anthrax vaccine is administered immediately alongside a 60-day antibiotic course post-exposure to establish long-term active immunity as the antimicrobial protection concludes.
Individuals exposed to aerosolized Bacillus anthracis spores require post-exposure prophylaxis (PEP) before clinical signs develop to prevent fatal systemic disease. The standard protocol involves a 60-day oral course of antimicrobial therapy—typically ciprofloxacin, doxycycline, or levofloxacin—combined with a three-dose series of the anthrax vaccine adsorbed (AVA) administered at 0, 2, and 4 weeks. If clinical symptoms have already started, treatment intensifies immediately to multi-drug intravenous broad-spectrum bactericidal regimens alongside anthrax antitoxins.
Public health authorities and clinicians identify potential biological events by looking for epidemiologic anomalies, such as an unexpected surge of severe, acute illness in previously healthy individuals, unusual clustering of symptoms, or the appearance of an endemic disease outside its typical geographic distribution. The presentation of rare conditions—such as multiple cases of mediastinal widening indicating inhalational anthrax, sudden symmetric descending paralysis signaling botulism, or vesicular skin rashes characteristic of smallpox—alerts medical networks to initiate biodefense surveillance.
practical personal preparedness kit should focus on standard emergency medical supplies rather than attempting to stockpile specialty prescription antimicrobials, which risk drug expiration, adverse side effects, and inappropriate use against viral pathogens. Maintain a minimum 14-day supply of your personal chronic prescription medications, a well-stocked first aid kit, basic electrolyte rehydration solutions, N95 respirators to filter airborne particles, and a battery-powered radio to receive official directives regarding public health prophylactic distribution sites (Points of Dispensing).
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab